It is based on the theory of 1+1=3 or 1+1+1>3 curative effect enhancement by tumor combined therapy, and it can be used solely, or with the combination of chemotherapy or actinotheraphy or both for tumor hyperthermia.
Different chemotherapy regimens were applied to 158 cases with advanced cancer NRL-001 Double RF Tumor Hyperthermia System was applied to heat the tumor sites at 41℃~43℃ for 60~90 minutes,with 5~20 times (average 9 times) for each patient.
The concepts of effective therapeutic depth (defined as the distance in which, the temperature is in 41℃~45℃) and the effective therapeutic volume ( defined as the volume in which, the temperature is in 41℃~45℃) are offen used to test the heating properties in the clinics of hyperthermic oncology.
This complex sensor can not only be used for clinical practices such as tumor hyperthermic oncology,but also can be used for temperature measurements and controls in productions.
Tumor hyperthermia is a rediscovered technique of oncotherapy which has confirmed value in many studies on cell cultures, rodent and mammalian tumors as well as first investigations on patients with tumors.
Local tumor hyperthermia (42-43°C) during moderate whole body hyperthermia (40°C) and hyperglycemia (5 ? 10-3 g ml-1) led to an amplification of tumor hyperacidification of ΔpH = -0,47 ± 0,19 in 12 from 20 animals.